Hints and tips:
Related Special Reports
...The US pharmaceutical company has agreed to extend its contract from 2023 to 2026, according to two people with knowledge of the talks....
...The fresh proposal includes a new provision for member states to pay half price — about €10 — for each cancelled dose, according to people close to negotiations, who also confirmed the annual 70mn figure...
...J&J said it had already resolved 95 per cent of those cases, and had agreements in principle to resolve claims brought by US states and talc suppliers....
...The decision to block the deal between the world’s biggest gene sequencing group and cancer screening start-up Grail was made in September 2022 after a referral by France and other member states....
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...“All eyes will be on what state-funded systems like the UK do as they scrutinise the risk-benefit calculation.”...
...Fink said at the time that the debate references were “a sad commentary on the state of American politics”....
...The world’s top global tech and pharmaceutical companies have set up in the country and are major contributors to state coffers via their taxes....
...The US government named 10 of the best-selling drugs as the first to face tough price regulations in a bid to slash healthcare costs, marking the biggest shake-up for the pharmaceutical industry in decades...
...Henry Liu, director of the FTC’s bureau of competition, said the proposed resolution sent a “clear signal” that the FTC and its state partners would scrutinise pharmaceutical mergers that enabled such practices...
...Its 12.5 per cent tax rate helped attract global tech and pharmaceutical companies and has led to bumper returns....
...State-level leaders during the pandemic had to set guidelines on mask-wearing, school attendance and vaccine passports, angering those who found them either too lax or too restrictive....
...The EMA had given it a preliminary nod last year on the back of the initial, positive data, allowing member states to prescribe it....
...Even if the UK gets a stable government (one that doesn’t flip-flop on net zero or repeatedly threaten to legislate in defiance of its international treaty obligations) Brexit creates a permanent state of...
...US pharmaceutical company Pfizer sold the shots, developed with Germany’s BioNTech, for about $19 a dose under the contract signed in 2021, but the new price has not been disclosed....
...And you don’t have diversity and tools, and even enough volume to support people in countries that don’t have the money that we’re fortunate enough to have in the United States and western Europe,” he said...
...To paraphrase William Shakespeare’s Hamlet, something is rotten in the state of Illumina,” Icahn said in the letter to shareholders....
...“It will require J&J to litigate talc claims on a state-by-state basis and leave talc as an ongoing overhang on shares.”...
...Janssen is the pharmaceutical division of J&J....
...He added negotiations with the state health insurer aimed at agreeing a further price reduction from April 1 had not reached a conclusion....
...China International Capital Corporation O: 7; L: 7; I: 7; Total: 21 The legal team at the part state-owned investment bank worked with the business to design and launch a digital platform that connects Chinese...
...Brent Wisner, the co-lead liaison counsel for claimants in the Zantac California state litigation, said he was focused on pursuing the litigation in the state courts....
...But the first few that did join the company learnt that the drive to develop reduced-risk tobacco products that help people quit smoking could save more lives than many pharmaceutical products....
...Legalisation of cannabis in some states paves the way for greater use of psychedelics. Denver has already decriminalised psilocybin....
...In this week’s episode, we hear from White House Covid coordinator Ashish Jha, professor of molecular medicine and cardiologist Eric Topol and the FT’s US pharmaceuticals correspondent Jamie Smyth on what...
International Edition